Healthcare payer M&A showed mixed momentum in 2020, with growth in some subsectors but ongoing volatility and uncertainty. Payers benefited in the short term from reduced elective procedures, yet continue to weigh longer‑term impacts, including a possible resurgence in procedures, the rapid shift to telehealth, and the evolving health effects on Covid‑19 patients. Despite these unknowns, signs point to increased deal activity in 2021, especially in areas accelerated by the pandemic. Expected growth includes transactions focused on software for remote visits and healthcare payments, along with rising private equity interest aimed at building scalable businesses that could become attractive acquisition targets.

Join for free to read